Numerous studies have described the implication of Bcl-2 family members for LSC survival, but the inhibition of Bcl-2 with ABT-737 was reported to be insufficient for preventing disease progression in a mouse lymphoma model [39]. The gene discussed is BCL2; the disease is lymphoma.